Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Arrhythmias

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 62 articles: HTML format

Single Articles

June 2026
1. BRADACH D, Ajith S, Sheik T, Qadri SA, et al
   Does early catheter ablation (<1?year) reduce atrial fibrillation recurrence compared with delayed ablation: A systematic review and Meta-analysis.
   J Cardiol. 2026 Jun 10:S0914-5087(26)00110-3. doi: 10.1016/j.jjcc.2026.
   PubMed     Abstract available
   
   
   
2. KATAOKA N, Imamura T, Uchida K, Kinugawa K, et al
   The clinical impact of genetic testing in comprehensive cardiomyopathies.
   J Cardiol. 2026;87:496-501.
   PubMed     Abstract available
   
   
   May 2026
3. SAKAI T, Takemoto M, Oginosawa Y, Yamada A, et al
   Efficacy and Safety of Right Neck Phrenic Nerve Pacing in Patients Undergoing Cryoablation for Atrial Fibrillation.
   J Cardiol. 2026 May 20:S0914-5087(26)00103-6. doi: 10.1016/j.jjcc.2026.
   PubMed     Abstract available
   
   
   
4. KOMATSU T, Katano T, Suda S, Iguchi Y, et al
   Nonstenotic carotid artery plaque in patients with cryptogenic stroke after ICM: A sub-analysis of the LOOK study.
   J Cardiol. 2026;87:434-439.
   PubMed     Abstract available
   
   
   April 2026
5. SAITO Y, Nagashima K, Kitano D, Miyauchi K, et al
   Clinical utility of the BREATH score for heart failure risk stratification in patients with atrial fibrillation.
   J Cardiol. 2026 Apr 2:S0914-5087(26)00068-7. doi: 10.1016/j.jjcc.2026.
   PubMed     Abstract available
   
   
   
6. MORI Y, Fukuma S
   Clinical engagement and cardiovascular outcomes of screening-detected atrial fibrillation in working-age adults.
   J Cardiol. 2026 Apr 2:S0914-5087(26)00070-5. doi: 10.1016/j.jjcc.2026.
   PubMed    
   
   
   March 2026
7. MIYAHARA D, Kida K, Nabeta T, Yoshioka K, et al
   Prognostic value of the clinical phenotype in patients with cardiac sarcoidosis: SARCO phenotype.
   J Cardiol. 2026;87:230-237.
   PubMed     Abstract available
   
   
   February 2026
8. FUJIKI S
   Antiarrhythmic potential of SGLT2 inhibitors: Mechanistic insights and clinical evidence.
   J Cardiol. 2026;87:128-135.
   PubMed     Abstract available
   
   
   January 2026
9. YAGINUMA H, Kitahara H, Suzuki S, Ohno Y, et al
   Prognostic impact of chronic kidney disease in patients with atrial fibrillation after percutaneous coronary intervention.
   J Cardiol. 2026 Jan 6:S0914-5087(25)00323-5. doi: 10.1016/j.jjcc.2025.
   PubMed     Abstract available
   
   
   November 2025
10. SATO H, Takahashi N
    Response to "Contemporary clinical implication of catheter ablation for atrial fibrillation in Japan".
    J Cardiol. 2025 Nov 27:S0914-5087(25)00291-6. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
11. KANAI M, Yazaki K, Ejima K, Kataoka S, et al
    Prognostic Comparison of Improved versus Preserved Left Ventricular Systolic Function Following Atrial Fibrillation Ablation in Heart Failure Patients.
    J Cardiol. 2025 Nov 20:S0914-5087(25)00281-3. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    October 2025
12. SAIRAKU A, Sumita Y, Kanaoka K, Nakano Y, et al
    National trends and in-hospital costs of atrial fibrillation ablation by energy source in Japan: Insights from the JROAD-DPC nationwide database.
    J Cardiol. 2025 Oct 25:S0914-5087(25)00263-1. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
13. TOMITA H, Okumura K
    Current risk stratification schemes for preventing ischemic stroke in patients with nonvalvular atrial fibrillation: HELT-E(2)S(2) and CHA(2)DS(2)-VA scores.
    J Cardiol. 2025 Oct 24:S0914-5087(25)00262-X. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
14. KATAOKA N, Imamura T
    Contemporary clinical implication of catheter ablation for atrial fibrillation in Japan.
    J Cardiol. 2025 Oct 6:S0914-5087(25)00250-3. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
15. KAI T, Izumo M, Sekiguchi M, Tanaka T, et al
    Prevalence and clinical outcomes of permanent conduction disturbances after transcatheter aortic valve replacement.
    J Cardiol. 2025;86:395-402.
    PubMed     Abstract available
    
    
    September 2025
16. MATSUNAGA-LEE Y, Egami Y, Ohsuga M, Abe M, et al
    Novel tailored very-high-power short-duration radiofrequency ablation around the esophagus guided by left atrial voltage.
    J Cardiol. 2025;86:249-255.
    PubMed     Abstract available
    
    
    August 2025
17. HASEGAWA K, Stevenson WG
    Antithrombotic Management in Catheter Ablation for ventricular arrhythmias -Mini review.
    J Cardiol. 2025 Aug 21:S0914-5087(25)00210-2. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
18. WATTANACHAYAKUL P, Yanpiset P, Kulthamrongsri N, Prasitsumrit V, et al
    Prognostic values of atrial high-rate episodes on mortality risks in CIED patients.
    J Cardiol. 2025;86:194-201.
    PubMed     Abstract available
    
    
    July 2025
19. SATO H, Takahashi N
    Temporal and geographical trends in anticoagulant therapy and catheter ablation for atrial fibrillation in Japan, 2014-2022.
    J Cardiol. 2025 Jul 23:S0914-5087(25)00192-3. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
20. MAO F, Sun Y, Du X, Fu G, et al
    Surface steel ball calibration - A novel method for facilitating fluoroscopic measurement during implantation of WATCHMAN.
    J Cardiol. 2025;86:32-37.
    PubMed     Abstract available
    
    
    June 2025
21. AIZAWA N, Tanno K, Furuya T, Ishinaga T, et al
    Very high-power short-duration ablation for superior vena cava isolation in patients with recurrent atrial fibrillation.
    J Cardiol. 2025 Jun 28:S0914-5087(25)00168-6. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    May 2025
22. YAMAGISHI Y, Watabe T, Nakahara D, Taniguchi K, et al
    Characteristics of anxiety about returning to work after implantable cardioverter defibrillator implantation in Japan.
    J Cardiol. 2025 May 30:S0914-5087(25)00143-1. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
23. AIJAZ A, Magsi IA, Zeeshan I
    Critique on "mitral regurgitation in atrial fibrillation: is a simple repair enough to tackle a complex problem?".
    J Cardiol. 2025 May 27:S0914-5087(25)00135-2. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
24. EGAMI Y, Kobayashi N, Sugino A, Abe M, et al
    Impact of Sinus Rhythm Maintenance After Repeat Catheter Ablation on Clinical Outcomes in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2025 May 20:S0914-5087(25)00127-3. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    April 2025
25. NAKANO T, Oka T, Okayama K, Tanaka N, et al
    Association between oral anticoagulants continuation on thromboembolism and bleeding events in patients with CHADS(2) score 0-2 points after catheter ablation for persistent atrial fibrillation.
    J Cardiol. 2025 Apr 24:S0914-5087(25)00103-0. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
26. NISHINARITA R, Oikawa J, Arao K, Sugisaki K, et al
    Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation.
    J Cardiol. 2025 Apr 2:S0914-5087(25)00097-8. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
27. SHINOHARA M, Saji M, Koike H, Ohara H, et al
    Current evidence and indications for left atrial appendage closure.
    J Cardiol. 2025;85:268-274.
    PubMed     Abstract available
    
    
    March 2025
28. OKAJIMA T, Ishikawa S, Uemura Y, Ozaki Y, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00088-7. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
29. AWAD AK, Elbahloul MA, Gamal A, Attia AN, et al
    Efficacy of surgical ablation and left atrial appendage occlusion in patients with AF undergoing coronary artery bypass grafting: A network meta-analysis.
    J Cardiol. 2025;85:177-185.
    PubMed     Abstract available
    
    
    
30. KAWAJI T, Hayashi T, Nishimura T, Nagashima K, et al
    3D mapping quest: How far can we see with recent advances in 3D mapping?
    J Cardiol. 2025;85:204-212.
    PubMed     Abstract available
    
    
    February 2025
31. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    Author's reply to "how to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation".
    J Cardiol. 2025 Feb 14:S0914-5087(25)00063-2. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
32. TALPUR H, Mustafa G
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2025 Feb 13:S0914-5087(25)00059-0. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
33. ALBAKAA NK, Sato K, Kawamatsu N, Yamamoto M, et al
    Imaging characteristics of patients with cardiac sarcoidosis who presented with ventricular arrhythmias.
    J Cardiol. 2025 Feb 12:S0914-5087(25)00035-8. doi: 10.1016/j.jjcc.2025.
    PubMed     Abstract available
    
    
    
34. KATAOKA N, Imamura T
    How to indicate left atrial posterior wall isolation adjunctive to conventional pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2025 Feb 6:S0914-5087(25)00020-6. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
35. DIMITRIADIS K, Pyrpyris N, Iliakis P, Kanatas P, et al
    Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
    J Cardiol. 2025;85:79-87.
    PubMed     Abstract available
    
    
    
36. WAKAMATSU Y, Nagashima K, Watanabe R, Hirata S, et al
    Beyond the lens: Unveiling the invisible atrioventricular node in the era of high-density mapping.
    J Cardiol. 2025;85:56-62.
    PubMed     Abstract available
    
    
    January 2025
37. BASILE P, Guaricci AI
    Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
    J Cardiol. 2025 Jan 31:S0914-5087(25)00012-7. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
38. KATAOKA N, Imamura T
    How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts.
    J Cardiol. 2025 Jan 20:S0914-5087(25)00006-1. doi: 10.1016/j.jjcc.2025.
    PubMed    
    
    
    
39. BAZOUKIS G, Hui JMH, Saplaouras A, Efthymiou P, et al
    The impact of new-onset atrial fibrillation in the setting of acute coronary syndrome.
    J Cardiol. 2025 Jan 7:S0914-5087(24)00233-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
40. PASCOE MA, Kolodziej A, Birks EJ, Vaidya G, et al
    Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis.
    J Cardiol. 2025;85:43-44.
    PubMed     Abstract available
    
    
    December 2024
41. KHAN S, Javed R, Amin S
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2024 Dec 12:S0914-5087(24)00226-0. doi: 10.1016/j.jjcc.2024.
    PubMed    
    
    
    
42. KAMADA H, Iriki Y, Yoshimoto I, Ninomiya Y, et al
    Incidence and predictors of persistent iatrogenic atrial septal defect following catheter ablation.
    J Cardiol. 2024;84:372-378.
    PubMed     Abstract available
    
    
    October 2024
43. KOMURO J, Kaneko H, Suzuki Y, Okada A, et al
    Unawareness of being prescribed medications for diabetes and incident cardiovascular disease.
    J Cardiol. 2024;84:294-299.
    PubMed     Abstract available
    
    
    September 2024
44. SONG ZQ, Lu XY, Xu YP, Lin H, et al
    The role of left atrium posterior wall isolation in patients undergoing catheter ablation for atrial fibrillation.
    J Cardiol. 2024 Sep 26:S0914-5087(24)00180-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
45. BASILE P, Monitillo F, Santoro D, Falco G, et al
    Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring.
    J Cardiol. 2024 Sep 13:S0914-5087(24)00177-1. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
46. MATSUOKA Y, Sotomi Y, Hikoso S, Sunaga A, et al
    Extensive ablation for elderly patients with persistent atrial fibrillation: insights from the EARNEST-PVI prospective randomized trial.
    J Cardiol. 2024 Sep 7:S0914-5087(24)00173-4. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    August 2024
47. YOSHII T, Amano M, Moriuchi K, Nakagawa S, et al
    Usefulness of exercise stress echocardiography for predicting cardiovascular events and atrial fibrillation in hypertrophic cardiomyopathy.
    J Cardiol. 2024 Aug 28:S0914-5087(24)00170-9. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
48. ROMERO CE, Pereira NM, Morales KP, Kerges Bueno BV, et al
    Echocardiographic factors associated with thromboembolic events in patients with cardiac amyloidosis without atrial fibrillation.
    J Cardiol. 2024 Aug 9:S0914-5087(24)00147-3. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    June 2024
49. OKISHIGE K, Tachibana S, Shigeta T, Yamauchi Y, et al
    Novel method to avoid serious injurious effects on the atrioventricular nodal (AVN) conduction during catheter ablation of the AVN slow pathway utilizing cryofreezing energy.
    J Cardiol. 2024;83:371-376.
    PubMed     Abstract available
    
    
    May 2024
50. YAMAGUCHI T
    Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective.
    J Cardiol. 2024 May 27:S0914-5087(24)00096-0. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
51. KURODA S, Kawamura I, Sahashi Y, Kuno T, et al
    The significance of non-sustained ventricular tachycardia on life-threatening ventricular arrhythmia events in patients with non-ischemic cardiomyopathy in the contemporary era: A systematic review and meta-analysis.
    J Cardiol. 2024 May 14:S0914-5087(24)00086-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
52. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    PubMed     Abstract available
    
    
    March 2024
53. BAZOUKIS G, Saplaouras A, Efthymiou P, Yiannikourides A, et al
    Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature.
    J Cardiol. 2024 Mar 31:S0914-5087(24)00053-4. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    
54. IMBURGIO S, Johal A, Akhlaq H, Klei L, et al
    Fatal ventricular arrhythmias in myocarditis: A review of current indications for defibrillator devices.
    J Cardiol. 2024 Mar 27:S0914-5087(24)00054-6. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    February 2024
55. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    PubMed     Abstract available
    
    
    December 2023
56. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    November 2023
57. YAMAMOTO T, Nambu Y, Bo R, Morichi S, et al
    Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy.
    J Cardiol. 2023;82:363-370.
    PubMed     Abstract available
    
    
    
58. NARUMI T, Naruse Y, Miyajima K, Kaneko Y, et al
    Actual conditions of atrial septal lead implantation and the factors related to successful implantation.
    J Cardiol. 2023;82:371-377.
    PubMed     Abstract available
    
    
    
59. MARARENKO A, Udongwo N, Pannu V, Miller B, et al
    Intracardiac leadless versus transvenous permanent pacemaker implantation: Impact on clinical outcomes and healthcare utilization.
    J Cardiol. 2023;82:378-387.
    PubMed     Abstract available
    
    
    October 2023
60. WENG CJ, Li CH, Lin YJ, Chang SL, et al
    Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation.
    J Cardiol. 2023 Oct 12:S0914-5087(23)00247-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
61. HARA H, Kubo S, Nakajima Y, Matsumoto T, et al
    Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00240-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    September 2023
62. NAGASE T, Kikuchi T, Unno T, Arai R, et al
    Impedance-guided modified CLOSE protocol ablation can reduce ablation index necessary for pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2023 Sep 7:S0914-5087(23)00224-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum